News

Improving treatment outcomes of HF with preserved ejection fraction according to JACC: What does the success of gliflozins mean for the future?
The Journal of the American College of Cardiology (JACC) recently issued a scientific statement in which the authors thoroughly examined current knowledge on the epidemiology, pathophysiology, diagnosis, and treatment of heart failure with preserved ejection fraction of the left ventricle (HFpEF). Recent studies in this heterogeneous disease suggest the importance of carefully determining the HFpEF phenotype in a given patient based on pathophysiology, which enables better individualization of treatment. The authors also reflect on the success…

Current Reimbursement Conditions for the Dual Inhibitor IL-4/IL-13 Dupilumab

Digital Bridge Between the Brain and Spine: How an Implant Restored Walking Ability to a Paralyzed Patient − Case Study

A Cloned Monkey Survived to Adulthood for the First Time. Will We Soon Be Able to Clone Humans?

Can we properly manage osteoporotic fractures?

Meta-analysis of the Effectiveness of Romosozumab in the Treatment of Postmenopausal Osteoporosis

Lurasidone in a Patient with Paranoid Schizophrenia and Asperger's Syndrome – A Case Study

Clinical Significance of Smaller Gaps Between Strengths of Levothyroxine Preparations in the Treatment of Hypothyroidism

Generic Substitution of Levothyroxine in Practice

Options for Systemic Therapy of Advanced Stage Small Cell Lung Cancer
Conferences
News from the world of medicine
All conferences
Popular this week
- Multiple system atrophy
- Intermittent Fasting May Carry Significant Health Risks
- How Compassion Fatigue Threatens Doctors and Other Healthcare Workers
- Tuberous Sclerosis
- A device the size of a matchbox will help treat obstructive sleep apnea